Highlights Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 15:07:08 15/04/2026 BST			5-day change	1st Jan Change
57.70 ^USD	-0.66%		-2.36%	+7.16%

04-13	IDEAYA and Servier's eye cancer drug meets trial goal, paving way for FDA application	RE
04-10	Bristol-Myers Squibb Poised for In-Line Q1 Amid One-Off Volatility, RBC Says	MT

Highlights

04-13	IDEAYA and Servier's eye cancer drug meets trial goal, paving way for FDA application	RE
04-10	Bristol-Myers Squibb Poised for In-Line Q1 Amid One-Off Volatility, RBC Says	MT
04-10	Replimune's drug for advanced skin cancer fails to win FDA nod again	RE
04-09	Oxford Biotherapeutics and Bristol Myers Squibb Enter Strategic Collaboration to Discover and Develop Next-Generation T-Cell Engagers for Solid Tumours	CI
04-09	Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says	MT
04-07	Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline	RE
04-01		FA
04-01	Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment	CI
04-01	Wall Street Exhales
04-01	Spain's Rovi Closes Purchase of Bristol-Myers Squibb's Pharma Manufacturing Plant in Arizona, US	MT
03-30	ROIS Phoenix Inc completed the acquisition of A drug manufacturing facility located in Phoenix, Arizona from Bristol-Myers Squibb Company.	CI
03-29	Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy	CI
03-28	Takeda's psoriasis pill succeeds in late-stage studies	RE
03-28	Bristol Myers Squibb Announces Data from Phase 4 Clinical Trial Evaluating Symptom Stability, Safety and Tolerability of Cobenfy (Xanomeline and Trospium Chloride)	CI
03-25	Merck braces for Keytruda patent loss with $6.7 billion Terns bet	RE
03-23	Bristol Myers Squibb Presents New Camzyos Data At American College of Cardiology Annual Scientific Session & Expo 2026	CI
03-23	Insitro And Bristol Myers Squibb Expand Collaboration With Nomination Of New Targets	CI
03-20	Bristol Myers Squibb announces Opdivo received approval for two new classical Hodgkin Lymphoma indications in the U.S. and the European Union	CI
03-20	US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma	RE
03-19	Evotec Receives $10 Million Milestone Payment From Bristol-Myers Squibb	MT
03-19	Study Launch: Evotec Receives Major Milestone Payment from Bristol Myers Squibb	DP
03-19	Evotec Se Receives Milestone for Initiation of Clinical Study of Bms-986506 in Collaboration with Bristol Myers Squibb	CI
03-17	FTC monitoring how drug companies react to patent cliff, official says	RE
03-09	Bristol Myers Squibb Announces Positive Phase 3 Results From Successor-2 Study Of Oral Mezigdomide In Relapsed Or Refractory Multiple Myeloma	CI
03-09	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…